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Abstract

Results: The committee developed fundamental values,

Background: Patients with serious respiratory illness and their

caregivers suffer considerable burdens, and palliative care is a
fundamental right for anyone who needs it. However, the
overwhelming majority of patients do not receive timely palliative care
before the end of life, despite robust evidence for improved outcomes.
Goals: This policy statement by the American Thoracic Society

(ATS) and partnering societies advocates for improved
integration of high-quality palliative care early in the care
continuum for patients with serious respiratory illness and their
caregivers and provides clinicians and policymakers with a
framework to accomplish this.
Methods: An international and interprofessional expert

committee, including patients and caregivers, achieved consensus
across a diverse working group representing pulmonary–critical
care, palliative care, bioethics, health law and policy, geriatrics,
nursing, physiotherapy, social work, pharmacy, patient advocacy,
psychology, and sociology.

principles, and policy recommendations for integrating
palliative care in serious respiratory illness care across seven
domains: 1) delivery models, 2) comprehensive symptom
assessment and management, 3) advance care planning and
goals of care discussions, 4) caregiver support, 5) health
disparities, 6) mass casualty events and emergency preparedness,
and 7) research priorities. The recommendations encourage
timely integration of palliative care, promote innovative
primary and secondary or specialist palliative care delivery
models, and advocate for research and policy initiatives to
improve the availability and quality of palliative care for patients
and their caregivers.
Conclusions: This multisociety policy statement establishes a

framework for early palliative care in serious respiratory illness
and provides guidance for pulmonary–critical care clinicians and
policymakers for its proactive integration.
Keywords: quality of life; caregivers; healthcare disparities;
advance care planning; lung diseases
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Introduction
Palliative care is specialized medical care for
people living with serious illness and focuses
on providing relief of distressing symptoms
and improving the quality of life (QOL) for
both the patient and their family. Palliative
care is distinct from hospice care, which
focuses on care delivered at the very end of
life, whereas the integration of palliative care
is appropriate at any stage of a serious illness
and is most beneﬁcial when provided in
conjunction with curative or diseasemodifying treatments. Palliative care delivery
is the responsibility of all clinicians caring for
patients with serious respiratory illness. In
2008, the ATS (American Thoracic Society)
published a policy statement on palliative
care for patients with respiratory disease and
critical illness (1). That policy statement
described barriers to receiving
comprehensive palliative care and called on
the ATS to work with other professional
societies to support palliative care, enhance
education, and encourage funding of
palliative care research to provide best
practices. Since then, there has been
signiﬁcant growth in the ﬁeld of palliative
care (2), yet barriers to palliative care remain,
especially outside of hospitals and in
communities where patients with serious
respiratory illness are living and receiving
medical care.
This policy statement focuses on people
living with serious respiratory illness (e.g.,
chronic obstructive pulmonary disease
[COPD], interstitial lung disease [ILD], and
lung cancer) who often have a chaotic end of
life, seeking relief from debilitating
symptoms such as breathlessness in acute
care settings and receiving fragmented and
burdensome care that may not be aligned

II.
III.
IV.

V.
VI.

Health Disparities
Mass Casualty Events and
Emergency Preparedness
VII. Research Priorities
Conclusions

Comprehensive Symptom
Assessment and Management
Advance Care Planning and
Goals of Care Discussions
Caregiver Support

with their values and wishes. Even in high
medical resource settings, palliative care is
underresourced, particularly in outpatient
settings, and cannot meet the needs of
patients and their families (3, 4). This is
especially concerning in rural settings (4) and
developing countries, where 86% of the
global population lacks access to the highest
degree of palliative care (5). Given the
persistence of these known deﬁciencies for
decades, coupled with the anticipated
doubling of the burden of serious healthrelated suffering expected by 2060 (5), a
concerted effort to increase the accessibility
and quality of palliative care in pulmonary
and critical care medicine is urgently needed.
There are several important deﬁnitions
used by the committee in this policy
statement (Table 1). There are three distinct
levels of palliative care on the basis of clinician
training, care complexity, and setting
(primary, secondary or specialist, and tertiary
palliative care) (9, 10) (Figure 1). In this
statement, we also discuss serious respiratory
illness (6) and the importance of caregivers
who provide support for the medical needs or
daily activities of patients. This policy
statement is intended to build on previous
ATS work to 1) encourage timely, integrated
palliative care in respiratory illness,
highlighting current evidence; 2) review and
promote innovative primary and secondary or
specialist palliative care delivery models; and
3) advocate for research and policy initiatives
to improve the quality and availability of
palliative care in pulmonary and critical care
medicine. The committee used a values- and
principles-based approach (Table 2) to derive
recommendations designed to provide a
framework and identify policy priorities for
palliative care integration among patients with
serious respiratory illness.











Recommendation 1: The spectrum of
palliative care in serious respiratory
illness begins with primary palliative
care delivered by pulmonary and
critical care clinicians that is integrated
concomitantly with usual diseasemodifying therapies and should be
complemented by interprofessional
secondary or specialist palliative care
expertise when necessary.
Recommendation 2: Comprehensive,
individualized assessment of
symptoms and needs should occur at
every routine clinical encounter.
Recommendation 3: Advance care
planning should be an iterative and
longitudinal process of
communication that starts at the
diagnosis of a serious respiratory
illness and evolves with changes in
patient health status, goals, and
preferences.
Recommendation 4: Informal
caregivers should be identified and
incorporated as a part of the primary
unit of care with patients; effective
engagement is necessary to support
both patients and informal caregivers
throughout the illness journey,
including respite and bereavement.
Recommendation 5: Comprehensive
primary palliative care training of
pulmonary–critical care clinicians is
essential and can help mitigate
disparities in access; this should begin
early in professional training and
includes elements such as palliative
care terminology and communication,
advance care planning, active listening,
cultural awareness and sensitivity, and
symptom assessment and
management.

Dedication: This document is dedicated to ATS past-president J. Randall Curtis, M.D., M.P.H., the father of palliative care in pulmonary and
critical care medicine, whose fierce leadership and tireless efforts in critical care medicine, research, and policy on behalf of his patients and
their families inspire us to continue his legacy. Randy’s generosity, humility, enthusiasm, compassion, and courage, as well as his sage advice
and mentorship, have guided the careers (and sometimes lives) of many members of this committee, and we are forever indebted to him.
Most importantly, his example reminds us to prioritize the things we love.
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Table 1. Policy Statement Definitions
Serious respiratory illness (6)

Hospice care

ACP

GOC discussions

Informal caregiver or caregiver

Surrogate

Types of palliative care (9, 10)
Primary
Secondary
Tertiary

A respiratory condition (e.g., chronic obstructive pulmonary disease, pulmonary hypertension,
interstitial lung disease, lung cancer, etc.) that carries a high risk of mortality and symptom
burden (e.g., dyspnea and depression) and either negatively impacts a person’s daily function
or quality of life or negatively impacts their caregivers.
This care is not synonymous with palliative care. Hospice care is specialized care for people who
are experiencing a life-limiting illness and their caregivers so that they may live as comfortably
as possible. The hospice philosophy accepts death as the final stage of life but does not try to
hasten or postpone death. Bereavement services and respite care (i.e., short-term relief) for
families are a core component of this care. Settings can include inpatient units, community
facilities, and in-home care or a combination of these on the basis of needs. In the United
States, the Centers for Medicare and Medicaid Services provides a hospice care program for
people with a life expectancy of 6 mo or less.
This is a process that supports persons “at any age or stage of health in understanding and
sharing their personal values, life goals, and preferences regarding future medical care. The
goal of ACP is to help ensure that people receive medical care that is consistent with their
values, goals, and preferences during serious and chronic illness” (7).
This term is sometimes used in a narrow sense, specifically referring to discussions regarding
resuscitation preferences or “code status” during hospitalizations. This policy statement employs
a broader definition of this term, meaning any discussions and/or decisions regarding specific
treatments, the intensity of care, and future planning for care, including values, goals, and
preferences elicitations. GOC discussions are expected to occur across healthcare settings and
are considered an important component of ACP.
A person (e.g., partner, family member, or friend, among others) who provides unpaid support for
the medical needs or daily activities of someone living with a serious respiratory illness. This
committee acknowledges that this terminology frames these individuals only in terms of the
patient and the patient’s needs and does not encompass the totality of caregiver responsibilities,
contributions, or their own need for more individualized support and recognition.
A person designated to make decisions related to the health care of an individual in the event that
he or she is unable to do so (i.e., the patient is incapacitated). This person could be designated
in a legal document called an HCPA. The HCPA refers to both the legal document and the
person designated to make healthcare decisions. In lieu of a legal document, there are statespecific guidelines for who is the legally recognized person able to make health decisions
(e.g., spouse, adult child, etc.). Surrogate decisions are often guided by the substituted
judgment principle, in which a surrogate should attempt to determine what the patient would
have wanted under the given circumstances or what the patient would have decided if he or she
were competent to choose (8).
Care is provided by clinicians who are trained in basic tenets of palliative care but are not palliative
care specialists (e.g., pulmonary and critical care clinicians, primary care clinicians, etc.).
Care provided by trained palliative care specialists (e.g., nurses, physicians, advance practice
providers, social workers, chaplains, etc.). This care is sometimes referred to as specialist
palliative care.
Care provided by trained palliative care specialists at tertiary and quaternary medical centers and
includes caring for the most complex patients. This may include care in dedicated palliative care
units.

Definition of abbreviations: ACP = advanced care planning; GOC = goals of care; HCPA = medical or healthcare power of attorney.
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Recommendation 6: Emergency
response planning and preparedness
should include provisions for the
delivery of palliative care in the context
of a catastrophic event and/or resource
limitation. The palliative care response
must include both the existing and new
vulnerable populations who will be most
impacted by a catastrophic disaster and
should consider eight critical elements of
crisis palliative care provision: stuff, staff,
space, systems, sedation, separation,
communication, and equity.
Recommendation 7: Pulmonary–
critical care and palliative care

professional societies should create a
Pulmonary Palliative Care Research
Consortium to support collaborative
research opportunities with associated
funding mechanisms to advance
pulmonary palliative care science.

Methods
A diverse international, interprofessional
committee from relevant disciplines
developed this policy statement using an
iterative approach. Project co-chairs invited
international experts to join the committee to

ensure the full working group was diverse
and represented a breadth of professionals
(e.g., nurses, patients, caregivers,
pharmacists, physicians, physiotherapists,
social workers, and researchers), disciplines
(e.g., pulmonary–critical care, palliative
care, bioethics, law and policy, geriatrics,
nursing, physiotherapy, social work,
pharmacy, patient advocacy, psychology,
and sociology), and speciﬁc content area
expertise (e.g., advance care planning and
informal caregivers). In addition to a core of
ATS Behavioral Science and Health Services
Research Assembly members, the co-chairs
solicited representation from the following
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AMERICAN THORACIC SOCIETY DOCUMENTS
Primary Palliative Care
Who and Where
• Pulmonary and critical care clinicians
• Outpatient clinics and inpatient units

Secondary Palliative Care

Tertiary Palliative Care

Who and Where
• Palliative care specialist clinicians
• Outpatient clinics, inpatient units

Who and Where

What
• Symptoms
• Screening and regular assessments
(physical and psychological)
• Explore suffering
• Basic symptom interventions
• Assess caregiver needs
• ACP/GOC
• Explore values/preferences and
illness prognostic awareness
• Designate surrogate decision-maker
• Document conversations in
encounter notes and/or planning
tools (e.g., advance directive)
• Basic care coordination among specialists
and treating teams
• Navigate minor conflicts among family and
care partners
• Transition to hospice
• Trigger-based referral to secondary
palliative care

What
• Symptoms
• Complex assessments (physical,
psychological, spiritual,
psychosocial)
• Manage refractory symptoms or
severe suffering
• Complex symptom interventions
• Assess caregiver needs and
consider respite care
• ACP/GOC
• More focus on communication and
documentation of end-of-life care
preferences and transition to
comfort-based approaches
• Enhanced care coordination
• Major conflicts among family members or
treating teams
• Hospice coordination
• Referral to tertiary palliative care

When

When
• Concurrent with respiratory illness–directed
therapies

•
•

Palliative care specialist teams
Palliative care units (e.g., hospice care)

•

Symptoms
• Comprehensive spiritual, social, and
psychosocial care
• Focus on relieving suffering
• Intensive symptom interventions
• Caregiver support including
bereavement
ACP/GOC
• Complex communication about
end-of-life care, which may include
death with dignity if solicited
Care coordination with hospital and homeor community-based approaches

What

•

•

When
•
•

Approaching end of life
Cessation of most disease-directed
therapies

• Concurrent with respiratory illness–directed
therapies

Increased proficiency and expertise in palliative care
Figure 1. Levels of palliative care. This figure illustrates the who, where, what, and when of palliative care across three levels of increasing
proficiency and expertise (primary, secondary or specialist, and tertiary palliative care). ACP = advanced care planning; GOC = goals of care.

ATS groups: Patient Advisory Roundtable,
Nursing Assembly, Health Policy
Committee, Ethics and Conﬂict of Interest
Committee, Critical Care Assembly,
and Patient and Family Education

Committee to ensure balanced advice and
input from a variety of perspectives. To
achieve the greatest potential impact in
the ﬁeld, representatives with expertise
in serious respiratory illness from the

following national stakeholder societies
were also solicited: AAHPM (American
Academy of Hospice and Palliative
Medicine), CAPC (Center to Advance
Palliative Care), HPNA (Hospice and

Table 2. Fundamental Values and Principles of Palliative Care in Serious Respiratory Illness
1. All patients with serious respiratory illness are eligible for palliative care on the basis of needs and should have equitable access,
regardless of demographic characteristics (e.g., race/ethnicity, LGBTQIA1, age, sex, houselessness, and citizenship status),
geographic area of residence, stage of illness, or insurance status.
2. Primary and secondary or specialist palliative care should be provided throughout the course of the illness when needs arise,
integrated with illness-directed treatment, and should not be limited to patients in the final months or weeks of life.
3. Palliative care approaches include assessment and management of physical, psychosocial, ethical, and spiritual/existential
domains; therefore, this care should be interprofessional and engage all available and relevant disciplines.
4. Palliative care communications should be provided in the preferred language/linguistic style of patients and their caregivers,
partners, or family.
5. Pulmonary and critical care clinicians should prioritize the development and ongoing maintenance of primary palliative care
knowledge and skills.
6. Pulmonary and critical care professional societies should encourage a basic degree of primary palliative care knowledge and skill
development among its members, which may include approaches such as serious illness communication and symptom
assessment and management.
7. Policies and payment models that provide resources to facilitate palliative care delivery, including the provision of primary palliative
care, are essential.
8. Palliative care should be included in healthcare disaster and pandemic planning and preparedness activities as part of local,
regional, state, and federal disaster planning efforts.
9. Patients with their informal caregivers, partners, or family together are the principal unit of care to be identified, acknowledged, and
effectively supported.
10. Pulmonary and critical care and palliative care professional societies should support research, training, and professional education
to improve the provision of palliative care among patients with serious respiratory illness.

American Thoracic Society Documents
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Palliative Nurses Association), and SWHPN
(Social Work Hospice and Palliative Care
Network).
Policy statement development
proceeded in four phases (Figure 2). In phase
one (conceptualization), the project co-chairs
and selected committee members reviewed
existing relevant literature, including
previous ATS policies and policies of other
organizations (1, 11–13), to identify subtopic
domains and prepare introductory materials
across these domains. Next, in phase two
(preparation), small group facilitators
participated in teleconferences with co-chairs
to review small group structure and function.
In phase three (presentation, facilitation, and
exploration), presentations and small group
sessions were followed by full committee
discussions over two half-day virtual
meetings to begin developing consensus.
Small group sessions and discussions were
conducted using SWOT (Strengths,
Weaknesses, Opportunities, and Threats)
analysis (14), followed by loose variants of
the nominal group technique and Delphi
techniques (15) adapted from previous work
in rheumatology (16). The purpose of this
process was to work toward consensus in
identifying key priorities and identifying the
lack of consensus (“dissensus”) where it
existed. In phase four (integration and
compilation), additional rounds of Delphi
Phase 1
Conceptualization
(June 2016 – June 2020)

Phase 2
Preparation
(June 2020 – May 2021)

Phase 3
Presentation, Facilitation, and Exploration
(May 2021 – Sep 2021)

Phase 4
Integration and Compilation
(Oct 2021 – Feb 2022)

Figure 2. Multiphase iterative development
of the policy statement. This figure illustrates
the four phases of iterative development of
the policy statement over multiple years
through conceptualization (phase 1),
preparation (phase 2), presentation,
facilitation, and exploration (phase 3), and
integration and compilation (phase 4).

e48

techniques were used toward developing full
committee consensus. The writing
committee drafted the policy statement, with
successive drafts reviewed by the full
committee, who revised it in an iterative
process. The resulting ﬁnal draft was
subject to review by the ATS Documents
Editor, the ATS Board of Directors, and
anonymous peer reviewers from
cosponsoring societies, per ATS policy.
Potential conﬂicts of interest were disclosed
and managed in accordance with the policies
and procedures of ATS.

Palliative Care Domains
I. Delivery Models

Palliative care has undergone a dramatic
evolution since its inception in the 1960s,
from primarily community-based care
focused on patients approaching death
toward a vision for palliative care
integration concurrent with conventional
disease-modifying therapies throughout the
course of illness and across medical
treatment settings (17, 18) (Figure 3). The
beneﬁts of secondary palliative care are
unequivocal (19–22) and can be
extrapolated to patients with serious
respiratory illness. Today, the major
delivery models of specialist palliative care
include inpatient consultation teams, acute
palliative care units, and ambulatory, home,
or community-based outpatient services.
Hybrid models also include integrated,
interprofessional clinics where palliative
care specialists are embedded within a
pulmonary clinic (18, 23, 24). These hybrid
models are often disease-focused (e.g., lung
cancer) (24) or symptom-focused (e.g.,
breathlessness) (18, 25). Models also differ
in their team structures, care processes,
components, patient populations, and
reimbursement. Financial incentives can
inﬂuence delivery models, such as the
recently introduced Centers for Medicare
and Medicaid Services reimbursement
codes for advance care planning (ACP)
(26) and the Medicare Care Choices Model
demonstration allowing concurrent curative
and hospice care (27). Unfortunately,
access to palliative care is limited (4, 5),
particularly in outpatient settings, and the
looming specialist palliative care workforce
shortage will exacerbate the unmet
palliative care needs of patients (3, 28). As
a result, there is an increased emphasis on
the holistic model referred to as primary

palliative care, or the delivery of palliative
care by all clinicians who care for patients
with serious respiratory illness and their
families (9, 10).
In addition to potentially improving
access, primary palliative care has several
other potential beneﬁts as it can leverage
longitudinal therapeutic patient–clinician
relationships and trust, use a continuum of
care approach gradually integrating palliative
with usual medical care over time, and
normalize early components of ACP such as
identifying surrogate medical decisionmakers (29–32). Therefore, all pulmonary–
critical care clinicians should screen patients
for symptoms and palliative care needs and
know how to integrate core aspects of
palliative care within usual care for patients
with serious respiratory illness (11). Inherent
in this model are established best practices
facilitated by comprehensive palliative care
education and requisite training that
includes, but is not limited to, serious illness
communication and comprehensive
symptom assessment and management
(33–35). Clinician competencies should be
commensurate with the degree of
specialization and relevant to the populations
served (e.g., patients with COPD or ILD). To
date, the beneﬁts of a primary palliative care
model for those with serious respiratory
illness have not been well studied, with
limited evaluation of nurse practitioners in
oncology clinics (36, 37). Other key
unanswered questions regarding primary
palliative care models include the following:
1) discerning strategies for early
identiﬁcation of patients who may beneﬁt
from palliative care; 2) identifying potential
referral triggers for secondary palliative care
when needs exceed that of a frontline
pulmonary–critical care clinician (Figure 4);
and 3) developing the most effective ways to
teach pulmonary–critical care clinicians and
trainees (e.g., fellows and respiratory therapy
students) through continuing palliative care
education, comanagement delivery models
(particularly for more complex needs), and
health system-level policies to support
implementation. Sources for palliative care
education, training, and other resources are
included in Table 3.
The coronavirus disease (COVID-19)
pandemic brought unprecedented changes to
the delivery of healthcare, including the rapid
implementation of telehealth and virtual
technology (38). The potential value of
telehealth in delivering palliative care is
difﬁcult to overlook, especially in partnership
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Wellbeing/Functional Status

Primary and Secondary Palliative Care Integration in Serious Respiratory Illness
Diagnosis

Palliative Care
Intensity

Death

Primary Palliative Care

Collaborative Primary + Secondary Palliative Care

Secondary Palliative Care
Continue life-prolonging therapies, symptom
management, & evolving advance care planning

Shift focus from cure to hospice,
bereavement, respite, & survivorship

Time
- Lung cancer
- Pulmonary hypertension
- COPD/ILD

Hospitalization

Initiate Primary Palliative Care

Lung Transplant Referral

Initiate Secondary Palliative Care

Secondary palliative care is sometimes referred to as specialist palliative care.

Figure 3. Primary and secondary palliative care integration in serious respiratory illness. This figure has three panels. In the top panel, the
x-axis denotes patient wellbeing and function, and the y-axis denotes time. The top panel illustrates the hypothetical integration of palliative care
across illness trajectories of lung cancer (red dashed line), pulmonary hypertension (blue line), and chronic obstructive pulmonary disease/
interstitial lung disease (COPD/ILD; gold line), each punctuated by declines in wellbeing at hospitalizations (stars) and potential lung transplant
referral (diamonds). The integration of primary palliative care (orange circles) starts early (see Figure 4 for triggers), and the integration of
secondary palliative care (blue circles) is added later, but well before the end of life. In the middle panel, the x-axis denotes palliative care
intensity, and the y-axis denotes time. Primary palliative care increases in intensity after initiation (expanding orange triangle) as serious
respiratory illness worsens, and secondary palliative care starts later and also increases in intensity but layers on top of secondary palliative
care (expanding blue triangle). Through ongoing comanagement, a period of collaborative primary and secondary palliative care (overlapping
triangles) should occur as illness severity worsens through the end of life. The bottom panel illustrates how palliative care may evolve across a
continuum of serious respiratory illness. When illness is less severe, palliative care occurs concurrent with illness-directed therapies and then
shifts focus from cure to end-of-life care (e.g., hospice and bereavement support) near and after death. This figure is adapted by permission
from Iyer, AF. The Role of Palliative Care in COPD. Chest 2022;161: 1250–1262.

with community-based programs. Telehealth
may be particularly advantageous in
delivering palliative care to those with serious
respiratory illness who may have mobility
and transportation barriers and those in
remote or resource-limited settings (39, 40).
There also are legitimate concerns that
technology could worsen inequities (41), and
the unintended consequences of remote
delivery of palliative care for patients with
serious respiratory illness are largely
unexplored (42). However, models of
telehealth primary palliative care delivered in
a collaborative fashion with rural,
community nursing teams have been
successful (43, 44).

American Thoracic Society Documents

II. Comprehensive Symptom
Assessment and Management

Measurement is a fundamental principle of
illness management. As Edwards Deming
noted, “if you can’t measure it, you can’t
improve it”. Interprofessional approaches to
symptom assessment and management in
serious respiratory illnesses offer
opportunities for more effective
collaboration and coordination of care across
disciplines. This is vital as patients with
serious respiratory illness can experience
signiﬁcant symptom burden (45–48);
however, symptoms often go undetected
by clinicians (49–51) or are underreported
by patients during routine clinical

encounters (52). Detailed patient-reported
symptom assessments can increase rates of
symptom discussions between patients and
clinicians (53–55), intensify symptom
management by clinicians (53, 56, 57), and
improve patient symptom control and health
outcomes such as QOL (58–60).
Comprehensive, individualized symptom
assessments help determine the true impact
of an illness on a patient’s life, including
limitations of activity, psychological
manifestations of disease, missed work and
economic hardships, and effects on family
routines and overall wellbeing, among
others. Accurate symptom assessment is also
essential for consideration of additional
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Triggers for Initiating Primary and Secondary Palliative Care in Serious Respiratory Illness:
The Levers Model

Worsening Illness Severity

Thresholds
FVC or FEV1
<30%

Refractory
Breathlessness
(mMRC = 4)

Moderate
Breathlessness
(mMRC = 2–3)
FVC or FEV1
<50%

Lung Function

Symptoms

Cachexia/
Extreme Weight
Loss

Lung Transplant
Referral
ICU Admission

Reduced
Functional
Status
(6MWD
<400m)

Multiple
Hospitalizations

Care Needs

Exacerbations

Complicated
Bereavement/
Respite Needs

Supplemental
Oxygen

Advanced
Therapies

Many Support
Needs
(via CSNAT)

Secondary
Palliative Care

Primary
Palliative Care

Caregivers

Domains
Secondary palliative care is sometimes referred to as specialist palliative care.

Figure 4. Triggers for initiating primary and secondary palliative care in serious respiratory illness: the levers model. Hypothetical triggers for
primary and secondary palliative care occur across multiple domains: lung function, symptoms, care needs, exacerbations, advanced therapies,
and caregivers. The x-axis denotes worsening illness severity, whereas the y-axis denotes multiple domains, each with a circle functioning as a
lever that can move up or down, crossing a threshold for primary or secondary palliative care, illustrated by the dashed lines. Any one or
multiple domains can cross a trigger threshold for consideration for primary or secondary palliative care initiation. For example, a person can
trigger consideration for primary palliative care when their FEV1 drops below 50% predicted (lung function domain). Also, a person can trigger
consideration for secondary palliative care when their breathlessness becomes severe on the Modified Medical Research Council (mMRC)
(symptoms domain). 6MWD = 6-minute-walk distance; CSNAT = carer support needs assessment tool. This figure is adapted by permission from
Iyer, AF. The Role of Palliative Care in COPD. Chest 2022;161: 1250–1262.

therapeutic approaches and prognostication
(61–66).
Individualized, evidence-based symptom
assessments should occur routinely to assess
change and identify new symptoms.
Important symptoms to assess among patients
with serious respiratory illness include chronic
dyspnea or breathlessness, episodes of
dyspnea crisis, cough, pain, fatigue,
sleep disturbances/insomnia, psychological
and spiritual distress or suffering (e.g., anxiety,
panic attacks, depression, existential angst,
and sense of meaning), and weight loss/
anorexia (47, 67–69) (Table 4). These
symptoms may present in isolation or as
symptom clusters, which are a nonrandom
distribution of symptoms suggesting a
common etiology or pathway (131–134).
Pain–insomnia–fatigue and dyspnea–cough
are commonly recognized clusters (135).
In addition, social assessments should be
conducted periodically, including patient
relationships with their partners or
caregivers with attention to caregiver support
and strain, as there is a signiﬁcant correlation
between patient and caregiver health status
(20, 25, 136–138).
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Central to symptom management in
several serious respiratory illnesses is
pulmonary rehabilitation; for people with
COPD and ILD, it is an effective intervention
for breathlessness, fatigue, and emotional
symptoms (139, 140). This and other
nonpharmacologic treatment options may
complement disease-directed pharmacologic
therapies such as inhalers, nebulizers, mucus
clearance medications, immunosuppressants,
and antiﬁbrotics, among others (66). Although
not exhaustive, some of the more common
pharmacologic and nonpharmacologic
therapies are listed (Table 5). Low-dose opioids
are the mainstay of refractory breathlessness
treatment in patients with advanced cancer;
however, they are often underused in those
with serious respiratory illness because of
concerns they may reduce respiratory drive
and hasten death. However, the potential for
serious opioid-related side effects may be
overstated, as a recent trial found that low-dose
oral sustained-release morphine improved
health status in patients with COPD without
causing hypercapnia or other serious adverse
effects (163). Additional advanced palliative
therapies may be considered in select patients if

the potential beneﬁts outweigh the risks
(e.g., endobronchial valves in COPD, palliative
radiation, or stents in lung cancer).
Clinicians should encourage self-care
maintenance among patients with serious
respiratory illness as it is an essential
treatment adjunct that can improve QOL,
reduce respiratory-related hospital
admissions, and decrease dyspnea (164).
According to the middle-range theory of
self-care in chronic illness, interventions may
focus on one of three related dimensions:
self-care maintenance, monitoring, and
management (165). Self-management of
breathlessness among patients with serious
respiratory illness should be a focus as
chronic breathlessness causes signiﬁcant
panic, distress, and desperation that
signiﬁcantly limits daily activities and social
life (166). Among patients with serious
respiratory illness, components of self-care
interventions include recognition and
treatment of exacerbations, physical activity
and exercise behaviors, and education and
tools to self-manage symptoms such as
breathlessness (164, 167). For instance,
clinicians can help patients and caregivers in
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Table 3. Sources for Palliative Care Education, Training, and Other Resources
Organization

Content Focus

Website

American Academy of Hospice and
Palliative Medicine

Professional organization for physicians specializing http://aahpm.org/education/overview
in hospice and palliative medicine, nurses, and
other healthcare professionals. Provides education
and advocacy.
American Thoracic Society
Medical society dedicated to accelerating the
www.thoracic.org
advancement of global respiratory health through
multidisciplinary collaboration, education, and
advocacy.
California State University Shiley Haynes Advance care planning and palliative care education www.csupalliativecare.org
Institute for Palliative Care
courses for health professionals and organizations
looking to develop their teams.
Cambia Palliative Care Center of
Provides palliative care education and training for
https://cpcce.uw.edu/
Excellence at the University of
clinicians and conducts research and quality
Washington
improvement projects to promote innovation in
delivering value-based, patient-centered care to
diverse populations across the lifespan.
Center to Advance Palliative Care
Provides healthcare professionals and organizations www.capc.org
with the training, tools, and technical assistance
necessary to provide quality health care for people
living with a serious illness.
End-of-Life Nursing Education
National and international education initiative to
www.aacnnursing.org/ELNEC
Consortium
improve palliative care through training of nurses
and other healthcare providers.
Fast Facts
Provide concise, practical, peer-reviewed, and
https://www.mypcnow.org/fast-facts/
evidence-based summaries on key palliative care
topics important to clinicians and trainees caring for
patients facing serious illness.
Get Palliative Care
Consumer-facing palliative care videos and
www.getpalliativecare.org
information.
Harvard Medical School Center for
Provides palliative care education for physicians,
https://pallcare.hms.harvard.edu/
Palliative Care
nurses, social workers, pharmacists, and other
healthcare professionals.
Hospice and Palliative Nurses
National professional organization that represents the www.advancingexpertcare.org/HPNA
Association (HPNA)
specialty of palliative nursing, which includes
hospice and palliative nurses. HPNA supports the
profession through education programs, research
initiatives, and advocacy.
Prepare for your care
Patient-centered tools to help make medical decision- www.prepareforyourcare.org
making easier for people and caregivers.
Respecting Choices
Guides organizations and communities to integrate
https://respectingchoices.org/
and disseminate evidence-based best practices
that ensure individual preferences and decisions for
health care are known and honored.
Social Work Hospice & Palliative Care
Advocacy and professional development through
https://www.swhpn.org
Network
education, evidence-informed best practice, social
work–informed research, and specialty certification.
VitalTalk
Evidence-based communication training for
https://www.vitaltalk.org
physicians and advanced practice providers
working with seriously ill patients and their families.

developing an action plan for breathlessness
with instructions for worsening symptoms,
including crises. These action plans may
include home spirometry monitoring,
starting an oral corticosteroid, temporarily
limiting strenuous activities, avoiding
tobacco products (if applicable), practicing
breathing–relaxation training, receiving
massage therapy, or notifying their clinicians
(168, 169). Patients and their caregivers can
become adept at preventing, controlling, and
American Thoracic Society Documents

managing the physical, psychological, and
social consequences of respiratory illness,
and clinicians should encourage self-care
management activities while acknowledging
their potential limitations.
III. Advance Care Planning and Goals
of Care Discussions

ACP is a process that supports persons “at
any age or stage of health in understanding
and sharing their personal values, life goals,

and preferences regarding future medical
care. The goal of advance care planning is to
help ensure that people receive medical care
that is consistent with their values, goals, and
preferences during serious and chronic
illness” (7). Goals of care (GOC) discussions
may help ensure that care is consistent with
patient preferences, and these discussions
can be framed around speciﬁc medical
interventions (e.g., intubation and
mechanical ventilation). However, this
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Table 4. Symptom Assessment Instruments
Symptom

Tool

Health-related quality
of life

Breathlessness

Brief Description

Validation

Chronic Respiratory
Questionnaire

25 items rated on 7-point Likert scale.
Focused on the last 2 wk.
Available in interviewer or selfadministered versions with optional
dyspnea domain.
Licensed.

Originally designed and validated for
patients with COPD (70).
Patients with COPD before and after
pulmonary rehabilitation (71).
Patients with ILD before and after
pulmonary rehabilitation (72).
Patients with COPD and ILD (73).

King’s Brief Interstitial
Lung Disease

15 items measuring three domains
(breathlessness and activities, chest
symptoms, and psychological).
Focused on last 2 wk, one question with
no time period.
Licensed.

Designed and validated for patients
with ILD (74).
Updated MCID in patients with ILD
(75).

St George’s Respiratory
Questionnaire

50 items measuring symptoms impacts.
Focus on 1, 3, or 12-mo recall.
Free to use for noncommercial entities.

Patients with COPD before and after
pulmonary rehabilitation (71).
Patients with ILD before and after
pulmonary rehabilitation (72).

Short-form 36-item Survey

36 items rated on Likert scales measuring
8 concepts, broadly categorized into
mental and physical component scores.
Focus on the past 4 wk and the current.
Free to use.

Patients with ILD before and after
pulmonary rehab (72).
Male patients with COPD (76).
Partially responsive to pulmonary
rehabilitation in male and female
patients with COPD (77).

Clinical COPD
Questionnaire

10 items rated on 7-point Likert scale.
Focuses on the past week.
Free to use.

Patients with COPD before and after
pulmonary rehabilitation (71).

Euro-QOL 5D

6 questions, allow for monitoring of
changes in self-reported health status
through time or in response to
treatment.
Free to use for noncommercial entities.

Patients with COPD (78).

Living with Idiopathic
Fibrosis

44-item questionnaire specific for patients
living with IPF.
Licensed.

Patients with IPF (79).

COPD Assessment Test

8 items rated on a 0–5 scale of severity.
Self-administered.
Licensed.

Developed and validated in patients
with COPD (80).
Responsive to pulmonary
rehabilitation in patients with COPD
(81).
Validated in patients with ILD (82).

Modified Medical
Research Council
Dyspnea Scale

Single item assessing breathlessness
severity on a scale of 0-4.
Free to use.

Predicts degrees of physical activity in
patients with COPD (83).
Comparison with CAT in patients with
COPD (84).
Patients with ILD (85).

Visual Analog Dyspnea
Scale

A single-item rating of breathlessness
along a visual line. Has the same
limitations as the NRS—single domains
measured only.
Free to use.

Validated in patients with COPD and
asthma against the Borg exertion
scale (86).
Validation in patients with ILD,
including MCID (87).

Numeric Rating
Scale

A single-item rating of 0 to 10. Modeled
from the NRS for pain. Only measures
one domain but can be used for multiple
separate symptom questions (e.g.,
breathlessness intensity and
breathlessness unpleasantness
questions).
Free to use.

Validated in patients with COPD with
high correlation against VADS (88).
Patients with COPD and ILD (73).

Dyspnea-12

12 items rated on a scale of 0 to 3
severity. Focuses on “these days”.
Free to use.

Developed and validated in patients
with COPD, ILD, and chronic heart
failure (89).
Validated in patients with ILD (90).

(Continued)
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Table 4. (Continued)
Symptom

Cough

Pain

Fatigue

Sleep

Tool

Brief Description

Validation

Respiratory Distress
Observation Scale

8 items rated on a scale of 0 to 2 severity
assessing the intensity and distress of
dyspnea among patients unable to
self-report.
Free to use.

Developed and validated in patients
with a pulmonary or cardiovascular
disorder and postoperative pain
and healthy volunteers (91, 92).

Leicester Cough
Questionnaire

19 items rated on 7-point Likert scale
across three domains (physical,
psychological, and social), measuring
the impact of cough. Self-administered.
Free to use.

Designed and validated for chronic
cough patients (93).
Validated for patients with COPD (94).
Validation in patients with ILD (85).

Cough Symptom
Score

2 items rated on a 0–5 scale assessing
cough symptoms during daytime and
nighttime.
No information on copyright.

Design and validation in chronic
cough patients (95).

Cough and Sputum
Assessment
Questionnaire

20 items measuring 4 domains (cough and
sputum symptoms and respective
impact). Focused on past 7 d. Selfadministered.
Licensed.

Development and validation in COPD
and bronchitis (96).
Responsive to exacerbations in
COPD (97).
Usage in ILD (98).

Pain Sensitivity
Questionnaire

17 items rated from 0 to 10.
Self-administered
No information on copyright.

Review of validation in COPD (99).

Geriatric Pain
Measure

24 items scored as yes/no or on a scale of
0–10. Measures multiple dimensions of
pain and can be self-administered.
Free to use.

Review of validation in COPD (99).

Brief Pain Inventory

Short form consists of 9 items. Selfadministered. Measures average, least,
and worse pain intensity.
Free to use.

Validation in patients with ILD (100).
Validation in COPD (101).
Validation in COPD during
exacerbations (102).

Short-form McGill Pain
Questionnaire

Short form consists of 2 subscales, 11
sensory items, and 4 affective. Rated on
a scale of 0–3.
Licensed.

Validation in patients with ILD (100).
Validation in COPD during
exacerbations (102).

Functional Assessment of
Chronic Illness
Therapy scale for
fatigue

Short version consists of 13 items modified
for COPD.
Free to use for noncommercial entities.

Development and validation of COPD
version (103).

Fatigue Severity Scale

9 items rated on 7-point Likert scale.
Free to use for noncommercial entities.

Validated in COPD (104).
Before and after pulmonary rehab in
general advanced respiratory
illness (105).

Manchester COPDFatigue Scale

27 items measuring three dimensions
(physical, cognitive, and psychosocial).
No information on copyright.

Developed and validated in COPD
(106).

Pittsburgh Sleep
Quality Index

10 items measuring 7 subscores, selfadministered. Focused on last month.
Free to use on request.

Validation in COPD against SGRQ
QOL score (107).
Validation in COPD (108).
Moderate correlation with CAT score
in COPD (109).
Associated with poor sleep quality in
ILD (110).

Berlin Questionnaire

10 items measuring three categories.
Free to use on request.

Validation in COPD against SGRQ
QOL score (107).
Did NOT predict obstructive sleep
apnea in patients with COPD (111)
or ILD (112).

Epworth Sleepiness Scale

8 items rated on 0–3 scale, selfadministered.
Licensed.

Validation in COPD against SGRQ
QOL score (107).
Did NOT predict obstructive sleep
apnea in patients with COPD (111).
Associated with poor sleep quality in
ILD (110).

(Continued)
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Table 4. (Continued)
Symptom

Tool

Psychological wellbeing

Brief Description

Validation

Hospital and Anxiety
Depression Scale

14 items rated on a 4-point scale, 7
assess depression, and 7 assess
anxiety.
Licensed.

Patient Health
Questionnaire-9

9 items rated on the Likert Scale,
assesses depression severity.
Free to use.
Long-form is 30 items. Short form
consists of 15 items measured
as yes/no responses.
Free to use.
21 items rated on a 4-point scale of
severity, focuses on 1–2 weeks.
Self-administered.
Licensed.
3-item assessment combining BMI,
unplanned weight loss, and acute
illness effect to assess malnutrition
risk. Clinician-assessed.
Free to use.
13-item scale adapted for use by family
members of patients in the ICU that
samples from all eight domains of
palliative care quality. No information
on copyright.
10-item scales; POS and IPOS contain
two similar measures, one completed
by staff, the other by patients to
assess: physical, emotional,
psychological, spiritual, and provision
of information and support dimensions.
Licensed.
9-item scale developed for use in
assessing the symptoms of
patients receiving palliative care.
Free to use.

Geriatric Depression
Scale
Beck Depression
Inventory II
Weight loss and
anorexia

Malnutrition Universal
Screen Tool

General palliative
care needs

Needs at the End of Life
Screening Tool

Palliative Care Outcomes
Scale/Integrated
Palliative Care
Outcome Scale

Edmonton Symptom
Assessment
Scale

Validated in COPD, including MCID
(113).
Correlation between dyspnea and
comorbidities in patients with ILD
(114).
Usage in COPD (115, 116).
Correlated with life event stress in
patients with COPD (117).
Responsive to pulmonary rehab in
ILD (118).
Validated in patients with COPD when
question 21 was excluded (119).
Not responsive to antifibrotic
treatment in ILD (120).
Usage in COPD (121).

Original version for use by patients
with cancer (122, 123).
Version adapted for use by family
members of patients in the ICU
(124, 125).
Usage in patients with serious
respiratory illness (e.g., lung
cancer, ILD, and COPD) in diverse
settings (25, 126, 127).

Usage in COPD (128, 129) and lung
cancer (130).

Definition of abbreviations: BMI = body mass index; CAT = COPD assessment test; COPD = chronic obstructive pulmonary disease;
ILD = interstitial lung disease; IPF = idiopathic fibrosis; IPOS = integrated palliative care outcome scale; MCID = minimally clinical important
difference; NRS = Numeric Rating Scale; POS = palliative care outcome scale; SGRQ QOL = St. George’s Respiratory Questionnaire quality of
life; VADS = visual analog dyspnea scale.

committee considered a broader deﬁnition of
GOC discussions as an important
component of the ACP process in
developing a better understanding of patient
values and preferences and does not
distinguish these as separate constructs.
The ethical principle of respect for patient
autonomy underpins the ACP process and
autonomous decisions as those that are made
intentionally and with substantial
understanding and freedom from controlling
inﬂuences (170). ACP positively impacts the
quality of end-of-life care (171, 172) and can
support patients, surrogates, and clinicians
by avoiding crisis-oriented decision-making
at the very end of life that may be
inconsistent with patient goals and increase
the burden and stress for surrogates
(173–176). This is particularly relevant for
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patients with serious respiratory illness who
are at elevated risk of losing the ability to
communicate because of unexpected acute
deterioration and the need for decisionmaking after acute respiratory failure (175,
177–180). As a result, pulmonary-critical care
clinicians are well-positioned to be leaders in
conducting ACP discussions among patients
with serious illness and their families.
ACP conversations may include the
creation of documents such as advance
directives, living wills, assignment of a
healthcare proxy, and POLST (Portable/
Physician Orders for Life-Sustaining
Treatment) that are readily available to the
healthcare team. These forms should be
reviewed and updated by patients on a
regular basis as health or conditions change.
However, completion of these documents

without considering the quality of the
preceding patient–clinician communication
should never be used as a quality metric.
In addition, ACP documents have limited
ability to address all potential health
scenarios; thus, healthcare proxies should be
prepared to make substituted judgments
(181–184) and, ideally, with patient consent,
should be included as active participants in
ACP discussions as healthcare decisions can
be overwhelming.
ACP consists of structured
communication and documentation that are
woven into the regular process of care
provided to patients and their families and
should begin in the early stages of respiratory
illness (Figure 5). This early and iterative
approach may help to normalize these
conversations and is a key recommendation
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Table 5. Complementary Pharmacologic and Nonpharmacologic Symptom Management Therapies in Serious Respiratory
Illness*
Symptom

Nonpharmacologic

Pharmacologic

Dyspnea or breathlessness

Acupuncture/acupressure/massage,
noninvasive positive pressure ventilation,
supplemental oxygen therapy, breathing or
relaxation techniques (e.g., pursed lip
breathing, breathing-relaxation training),
fan therapy (141–146)

Opioids (141–144)

Cough

Chest physiotherapy, speech therapy,
breathing exercises (147–149)

Opioids, neuromodulators, cromoglicic
acid/sodium cromoglycate, central
antitussive agents, GABA analogs
(150–153)

Pain

Acupuncture/acupressure/massage, music
therapy, surgical options (e.g., surgical
debulking and vertebroplasty) (154–157)

Opioids, antidepressants,
anticonvulsants, muscle relaxants,
anxiolytics, corticosteroids, topical
analgesics (158–160)

Psychological distress (e.g., anxiety and
depression)

Cognitive-behavioral therapy, counseling
and other support, coping skills training,
mindfulness-based stress reduction,
music therapy (161, 162)

SSRI or tricyclic antidepressants,
anxiolytics, ketamine, methylphenidate
(161, 162)

Definition of abbreviations: GABA = g-aminobutyric acid; SSRI = selective serotonin reuptake inhibitor.
*These approaches may be considered complementary to evidence-based and disease-directed pharmacologic and nonpharmacologic therapies (e.g.,
inhalers, nebulizers, mucus clearance and immunosuppressive medications, antifibrotics, and pulmonary rehabilitation, among others).

of the 2014 Institute of Medicine, Dying in
America Report (185). Early initiation of
ACP also is consistent with a recent
consensus deﬁnition that states that ACP
should support persons at any age or stage of
health (7). In addition, early ACP can
strengthen patient–clinician relationships
and provides an opportunity to introduce the
concept of palliative care (186–188).
Respecting Choices is one successful model
intended to normalize ACP communication
using a stepped approach in which the early

stages of the process may only focus on
asking patients to identify a medical
decision-making surrogate (189).
Improving uptake of ACP is not
without signiﬁcant challenges (190–192),
including the need for clinicians to acquire
specialized knowledge and skills through
feedback from ACP facilitators and/or
serious illness communication experts, as
well as ongoing opportunities to practice
these skills. Unfortunately, a lack of
knowledge or formal training in ACP persists

among pulmonary–critical care clinicians
(193–195) despite evidence that training and
education have positive effects on clinician
knowledge, attitude, and skills in conducting
ACP (196). For these reasons, completion of
serious illness communication and ACP
training should be required of all
pulmonary–critical care clinicians and
trainees as a core competency. This training
has been endorsed by representatives of the
ATS, the American College of Chest
Physicians, the Society of Critical Care

Continuum of ACP Integration in Serious Respiratory Illness
- Assess illness
understanding and
prognosis
- Introduce ACP
concepts and provide
information

Mild Illness

- Document these
preferences

- Review and confirm
preferences and goals
for current and future
care
- Continue to document
any changes to plan

- Name surrogate
decision maker/proxy

- Prepare treatment
plan

- Begin values-based
discussions about
preferences and
wishes/goals of care

Moderate-Severe Illness

- Enact treatment
plan based on
preferences
- Coordinate plan
with other clinicians

End of Life

Worsening Illness Severity
Figure 5. Continuum of advance care planning integration in serious respiratory illness. The continuum of ACP in serious respiratory illness
is a longitudinal process of communication that begins soon after illness diagnosis (stage 1: first arrow) and increases in intensity on the basis of
patient illness trajectory (stages 2–4). This process should be free of coercion, and clinicians should be alert to signs of patient distress or discomfort.
Patient-designated surrogates or healthcare proxies should be included across all stages with patient permission. ACP = advance care planning.
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Medicine, and the Association of Pulmonary
and Critical Care Medicine Program
Directors as Entrustable Professional
Activities (197).
Despite the potential importance of
ACP, it is worth noting emerging concerns
about the limited evidence supporting the
effectiveness of ACP in achieving goalconcordant care or in improving family
member perceptions of quality of care (190,
198). These ﬁndings may be because of the
inability to plan for or envision the myriad of
potential health situations that may arise
over the course of an illness and the inability
to foresee the emotional and psychological
challenges that can occur during in-themoment decision-making (190, 198). Some
dissensus existed within the committee
regarding the importance and future role of
ACP in serious respiratory illness, given
concerns about its effectiveness and the focus
within the ACP literature on the creation of
documents (e.g., advance directives). These
concerns reinforce the committee’s
consensus recommendations regarding ACP
for 1) early identiﬁcation of healthcare
proxies to enable them to better prepare for

in-the-moment decision-making using
substituted judgment; and 2) a shift in focus
away from document completion as the goal
of ACP to ensuring high-quality serious
illness communication occurs instead.
IV. Caregiver Support

Informal caregivers or caregivers (e.g., family
members, partners, and friends in unpaid
roles) provide essential support to patients
living with serious respiratory illness (199)
which can be rewarding and provide
caregivers a sense of accomplishment (200).
Caregivers are alternatively referred to as
“carers”, “care partners”, or sometimes
“supporters”. The caring role can also have
negative impacts on the caregiver(s), and
both patients and caregivers report a range of
unmet support needs throughout the illness
course (199, 201, 202). These can include a
need for disease education, learning how to
use respiratory equipment (e.g., oxygen
delivery devices), information about ﬁnancial
assistance, and help navigating the healthcare
system. Supporting the caregiver helps to
sustain caregiving, thereby supporting the
patient (See Box 1).

The ﬁrst step in supporting caregivers is
identifying them (199). Many patients and
caregivers do not recognize labels such as
“caregiver” or “carer” and can confuse these
labels with formal (i.e., paid) caregivers.
Caregivers see themselves in relational terms
(e.g., spouse or partner, child, or friend), and
patients may not accept the idea of being
“cared for” and so reject the label. It is,
therefore, better to reframe identifying
questions to patients as “who gives you help
and support at home?” (199, 201). Clinicians
can thus be instrumental in helping caregivers
access crucial support services and ﬁnancial
beneﬁts. Clinicians should also acknowledge
that there can be multiple caregivers
performing various roles, and these caregivers
may be geographically distant and can change
throughout the lifespan of the patient.
Therefore, ongoing identiﬁcation of
caregivers should be revisited during followup clinical encounters.
Condition-speciﬁc needs related to
caregivers of patients with serious respiratory
illness exist (201). For instance, patients
being evaluated for lung transplantation and
those on the transplant waitlist are required

Box 1. A Patient and Caregiver Perspective

Patient Voice:
Lung disease is awful. When you receive the bad news that you have a serious or terminal lung disease, you freeze, and you hear
nothing else. Then you hope that your clinician or team of clinicians can help guide you and your family through the process of
making tough treatment decisions. Decisions that reflect “who you are” and “how you want to live”. Sadly, this happens all too
seldom. Even clinicians with communication training can get it wrong when the conversation begins with an advance directive
checklist and questions about end-of-life decisions; you turn off, and you lose trust. Consequently, you miss out on a lot of support
that can help down the road. Clinicians need to first understand who a patient is as a person, what we are experiencing, and what
we want and need now and in the future before explaining how palliative care services can benefit us and our loved ones. Invite us
and our caregivers to be active participants in the team to set the ground rules for future interactions. We tend to be receptive to
receiving support if we believe we are being taken seriously and respected, which gains trust. Once trust is established, it makes it
much easier to introduce palliative care and end-of-life issues. It is critical that all clinicians are educated to communicate with
patients and our families using standard approaches, and hopefully, this can ensure we receive high-quality palliative care. It
doesn’t matter which member of the team introduces palliative care; getting help for the patient and caregiver is the goal.
Caregiver Voice:
We were told by my husband’s doctor we had 1–2 years when he was diagnosed with pulmonary fibrosis: we got 21 months
and made every minute count. Every day we said aloud, “I love you”. Although we had family and friends to help, the majority
of care fell on me as a spouse. Each day was a regimented, at times exhausting, schedule. No one discussed palliative care with
us. From life’s experiences and a little medical knowledge, I was able to ask the right questions to know what he really wanted
at life’s end. Visiting nurses started only 3 months before he passed away; hospice entered 10 days before his death. Both
assured me I had been correctly caring for him all those months by myself. What a relief to my heart. Our journey would have
been so much easier if palliative care was offered as soon as we were told his illness was terminal. Caregivers (spouses,
children, family members, and friends) need to be included and acknowledged at every medical visit, including when palliative
care is introduced. We need to know what the palliative care team can offer us and what they can’t provide (like care during a
crisis in the middle of the night). We need to be asked about our loved ones—we see and know things clinicians don’t.
Importantly, we need to be offered support and services for our own needs, too, including a support network.
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Table 6. Resources for Caregivers
Source

Websites

American Thoracic Society

Pulmonary Fibrosis Foundation
COPD Foundation
GO2 Lung Cancer Foundation
Help and advice for caregivers supporting someone with
breathlessness
American Lung Association:

Cystic Fibrosis Foundation
Action for Pulmonary Fibrosis
British Lung Foundation
Marie Curie: Managing Breathlessness
Society of Critical Care Medicine

Palliative Care for People with Respiratory Disease or Critical Illness
https://www.thoracic.org/patients/patient-resources/fact-sheets-az.php
- Palliative Care 2021: Palliative Care for People with Respiratory
Disease or Critical Illness
- Code Status 2022: Making Decisions about Serious Illness: What is
Code Status?
Making Decisions about Serious Illness: What is Code Status? www.
thoracic.org/patients/making decisions
https://www.pulmonaryfibrosis.org/patients-caregivers/medical-andsupport-resources/for-the-caregiver
https://www.copdfoundation.org/Learn-More/I-am-a-Caregiver/FAQfor-Caregivers.aspx
https://go2foundation.org/resources-and-support/support-groups/
https://supporting-breathlessness.org.uk/
https://www.lung.org/lung-health-diseases/lung-disease-lookup/lungcancer/family-and-friends/taking-care-of-yourself
https://www.lung.org/lung-health-diseases/lung-disease-lookup/
pulmonary-fibrosis/family-and-friends/find-caregiver-communities
https://www.cff.org/coping-while-caring-someone-cystic-fibrosis
https://www.actionpf.org/information-and-support/carer-family-friends
https://www.blf.org.uk/support-for-you/carers
https://www.mariecurie.org.uk/help/support/publications/living-withterminal-illness/managing-breathlessness
https://www.sccm.org/MyICUCare/THRIVE

Definition of abbreviation: COPD = chronic obstructive pulmonary disease.

to have an identiﬁed caregiver present at
transplant evaluation and through
posttransplant. Incorporating an assessment
of caregiver needs early in the lung
transplant process may be useful in
identifying caregivers who need more
support from the transplant team and/or a
palliative care consult in the posttransplant
period (202). Respiratory illnesses
also often require technical equipment
(e.g., mechanical ventilator and oxygen
delivery device), and palliative care may
include helping caregivers adjust to being
responsible for this equipment (203, 204).
Caregiver support is everyone’s
responsibility. The caregiver should be
acknowledged by the clinician and, at a
minimum, asked how he/she is doing
(directly or via the patient if the
caregiver is not present). Evidence-based
approaches (e.g., CSNAT-1 [Carer
Support Needs Assessment Tool
Intervention]) (205, 206) allow caregiver
support needs to be comprehensively
identiﬁed and addressed. Exploring
caregiver needs jointly with the patient
can raise patient awareness of caregiver
needs, but opportunities to talk about
American Thoracic Society Documents

needs separately from the patient should
also be provided. As needs change,
conversations should be revisited along
the illness trajectory, including into
bereavement. It can sometimes take a
clinician to identify caregiver needs, as
caregivers themselves may not recognize
them (i.e., being overprotective of the
patient). Timely/early provision of
information on support options can
reinforce the idea that caregivers also
need to care for themselves.
Clinicians should take a personcentered, caregiver-led approach to
meeting needs and identifying solutions.
Conversations around support needs are
enough to make caregivers believe they
are more supported. Other times
provision of information or education,
resource signposting (Table 6) or
referral is required (e.g., support groups,
advocacy organizations, psychological
support, or wellbeing services).
Caregivers should be kept informed and
involved in decision-making (with the
permission of the patient). Technology
can facilitate this for geographically
distant caregivers (e.g., telephone, video

conferencing, or Caring Bridge [207]),
although technical skills and preferential
barriers may exist.
V. Health Disparities

Given the evidence base for the beneﬁts of
palliative care in serious respiratory illness, it
is imperative that palliative care services are
equitably distributed, of similar quality, and
meet the needs of all eligible people. Access
to palliative care is a fundamental right
regardless of citizenship status, sex, race/
ethnicity, houselessness, LGBTQIA1 status,
rurality of home residence, or insurance
status. However, evidence demonstrates that
social, cultural, and economic factors
continue to limit access (208–210). Striking
disparities in access exist among socially
disadvantaged populations (211) as well as
rural communities (4, 212). Inequitable
access may be worse internationally,
especially in low- and middle-income
countries, as only 14% of the global
population has access to the highest degree of
palliative care, which outside of the United
States and Canada is concentrated in
Western Europe and Australia (5).
Synonymous with inadequate access to
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Table 7. Communication Considerations and Strategies among Disadvantaged Groups
Theme

Rationale

Implementation

Attitudes toward ACP
documentation

Patients who belong to some ethnic groups
are less likely to engage in ACP
because of cultural or religious beliefs or
distrust of the medical system as a result
of historical mistreatment of certain
communities (240–242).

Family support in
decision-making

There are important differences in cultural
orientation toward individualism or
communalism as values of how
individuals express their autonomy (243).
Therefore, clinicians may encounter
meaningful differences in family
involvement in serious illness decisionmaking by race and ethnicity.
Clarify potential discordant understanding
of the diagnosis or clinical situation
during discussions. Discordance affects
patient and family concerns and
understanding of their needs at all
stages of serious respiratory illness.
Tone of voice, facial expressions, body
language and gestures, and eye contact
are all forms of nonverbal
communication that are interpreted by
patients and families (244–246). Ensure
patient and family understanding when
interpreters are used (247, 248).
On the basis of responses, clinicians may
be able to provide patients and families
access to local or institutional resources
to address needs.

Offer referral to a clinician of a similar ethnic/cultural
background as some patients may be more comfortable
because of historical or structural discrimination.
Patients and families may also be encouraged to derive
support from their individual systems of faith or consult
their faith leaders for additional guidance.
Clinicians can use electronic medical record templates to
document detailed ACP discussions (allowing patients
to edit content through secured portals); printed copies
can be shared with patients.
If patients are amenable, clinicians should recommend
family or informal caregiver inclusion in serious illness
discussions.
Clinicians should inquire how and to what extent patients
want their families involved.

Lower health literacy

Non-English speakers

Refugees, immigrants,
and undocumented
citizens
Prognostication

Some cultures believe that discussing
death hastens the process and/or have
taboos against talking about death (243,
250–252).

At the outset of all discussions, ask patients and families
to describe their understanding of the situation,
diagnosis, or trajectory of illness.

Be cognizant of nonverbal communication.
Unless you are a native speaker, using translators as
professionally trained interpreters can be effective
cultural mediators (249).

Ask questions about patient and family backgrounds that
may inform decision-making (e.g., historical and political
context of their lives, place of birth, experiences with
poverty, experience with discrimination, and degree of
integration within their ethnic community).
Refrain from making assumptions about the degree of
information patients and families want.
Ask patients and families directly who they want to receive
information, how they want it conveyed, and how much
information they want to know.
Given the potential for prognostic uncertainty at the end of
life, providing categorical time estimates such as “days”,
“weeks”, or “months” without specifying a number may
facilitate a shared awareness (253, 254).

Definition of abbreviation: ACP = advanced care planning.

palliative care, racial and ethnic disparities in
opioid treatment and accessibility for pain
exist in many communities (213–220). This
is particularly meaningful as respiratory
illness disproportionately affects individuals
from disadvantaged populations (221), and
the lowest socioeconomic groups are up to
14 times more likely to be afﬂicted than the
highest group (222).
Even in similarly-resourced settings,
disparities in the quality of palliative care
are reported, particularly regarding clinician
communication (223–226). Breakdowns in
e58

communication can result in more intense
care at the end of life, increased in-hospital
deaths, and increased ﬁnancial burden and
complicated bereavement for families (227).
Ineffective communication also contributes
to reduced knowledge and completion rates
of advance care planning among African
Americans, Hispanics, and Asians
(228–233). Ensuring equitable access to
advance care planning among
disadvantaged populations is important;
however, these efforts should emphasize
efforts to determine patient readiness,

avoidance of coercion, and development of
a better understanding of cultural beliefs
and practices about and attitudes toward
end-of-life care choices enabling
individualized approaches. Underlying
ineffective communication may be a result
of a lack of cultural awareness, such as
proper language/linguistics regarding endof-life issues among clinicians, which likely
perpetuates the ongoing lack of trust among
some groups (234). Both the National
Quality Forum and National Consensus
Project for Quality Palliative Care identify
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Table 8. A Framework for Planning a Palliative Care Response during a Catastrophic Event on the Basis of the U.S. Task Force
on Mass Casualty Critical Care Guidelines (258)
Critical elements
Stuff
Staff
Space
Systems
Sedation
Separation
Communication
Equity

Description
A medication stockpile (“palliative symptom management kits”) should be created for long-term use by all
facilities, paramedics, and other healthcare professionals. Adequate PPE should be available to
facilitate safe care delivery.
Response plans should include all healthcare professionals with palliative care training as well as those
who can educate others in palliative care.
Usage of nearby locations or specialized wards may be necessary to ensure a peaceful and quiet
environment for dying patients.
Triage systems and virtual care models can be used to protect clinicians from the risk of infection while
also increasing their efficiency.
Sedation can offer comfort to patients whose symptoms are not responding to standard comfort
medications.
Patients can use video calling and other technologies to connect with family members to lessen the sense
of separation they may experience because of isolation measures. In-person visitation should be
considered if all parties are willing to accept risks and appropriate PPE is available.
Some patients may not want to undergo life-saving measures, so an understanding of patient wishes is
critical. It is important to maintain open communication with patients and their families.
All patients should have access to palliative care, regardless of status as a marginalized group, such as
those with disabilities, trauma, or poverty.

Definition of abbreviation: PPE = personal protective equipment.

the provision of culturally sensitive care as
one of eight core domains of high-quality
palliative care (235). Successful palliative
care interventions to reduce disparities have
included strategies to enhance cultural
awareness among clinicians and improve
health literacy among patients (231,
236–239). In addition, efforts to diversify
the palliative care workforce, including
healthcare professionals, social workers,
spiritual care workers, and community
health workers, are long overdue and
will require innovative solutions.
Comprehensive training (e.g., palliative care
terminology and communication; active
listening; and cultural traditions, awareness,
and sensitivity) of pulmonary–critical care
clinicians is essential in the provision of
primary palliative care. (Table 7)
VI. Mass Casualty Events and
Emergency Preparedness

Natural disasters and catastrophic mass
casualty events, such as COVID-19 or
inﬂuenza pandemics, are increasing in
frequency and severity, resulting in
widespread human, material, economic, and
environmental impacts yielding thousands of
victims whose needs overwhelm local and
regional healthcare systems, personnel, and
resources (255). These events generally fall
into two categories: 1) ‘‘big bang’’ single
incidents with immediate or sudden impact,
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such as airplane or train crashes, which yield
large numbers of casualties at the outset of
the event with few added over time; and
2) ‘‘rising tide’’ incidents that start with few
casualties such as pandemics or widespread,
ongoing exposures to chemical, biological,
and nuclear agents yielding a gradual
increase in the number of people affected
over time, rising to catastrophic numbers
with prolonged impact and necessitating a
more prolonged response (256). Such
conditions necessitate deploying scarce
resources in a manner that is different from
usual care, ranging from conventional to
contingency to crisis standards of care.
The COVID-19 pandemic has
highlighted increasing palliative care
needs across healthcare systems (257).
As illustrated by the pandemic, crisis
palliative care focuses on three domains:
1) management of symptoms; 2) discussion
of patient wishes, expectations, and values;
and 3) supporting families of those with lifelimiting injury or illness (209). At a
minimum, palliative care in catastrophic
disasters should include aggressive and
appropriate treatment of pain and other
symptoms and support and comfort for
patients, their families, and their clinicians
(256–260). Although the primary goal of a
coordinated response to a mass casualty
event is to maximize the number of lives
saved, a comprehensive response should also

seek to minimize the suffering of those who
may not survive (256). As healthcare
clinicians, there is always something to offer,
even at the end of life. A framework for
providing palliative care during a
catastrophic event is summarized in Table 8.
VII. Research Priorities

Currently, there are numerous challenges to
delivering palliative care to the right patient
at the right time. In fact, it is unclear who
ideally should receive palliative care, from
whom it should be delivered, and what
exactly the appropriate intervention(s)
should be. Patient and caregiver populations
for palliative care research studies should be
identiﬁed on the basis of needs for, and the
likelihood of beneﬁt from, palliative care
services. Palliative care trigger tools (i.e., tools
that indicate the need or suggest the timing
of referral) are available for speciﬁc patient
populations, such as those admitted to an
intensive care unit (ICU) (261). However,
given that palliative care triggers may not be
associated with palliative care needs (125),
measurement tools to differentiate patients
who could beneﬁt from primary vs
secondary palliative care further upstream in
the illness trajectory (i.e., in ambulatory
settings) would be helpful. Palliative care
outcome measures should expand beyond
healthcare system/usage outcomes (262, 263)
as palliative care services often include
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Table 9. Research Priorities
Categories

Examples

Study methodology
Measurement
Implementation

Content areas
Patient identification tools
Delivery models
Symptom management
ACP and decision-making
Caregivers
Disparities

Develop and test novel outcome measures (e.g., patient- and family-centered measures);
better define populations who should receive palliative care and the timing of initiation of
palliative care
Determine how best to operationalize interventions among the seriously ill, using novel
study designs when appropriate to evaluate, develop, and test implementation outcomes
such as acceptability, adoption, penetration, and sustainability
Measurement tools and the use of machine learning to differentiate patients who could
benefit from various degrees of palliative care (e.g., primary vs. secondary palliative
care) along the illness trajectory (i.e., in ambulatory settings)
Primary palliative care; primary plus secondary palliative care integration; multiprovider
and nonclinician integration; technology intervention such as leveraging electronic health
records and telehealth interventions
Patient and caregiver self-management strategies; studies identifying best practices in
pharmaceutical and nonpharmaceutical management of common symptoms in
respiratory illnesses (e.g., acute breathlessness, cough, and fatigue)
Improving ACP and “in-the-moment” decision-making; identifying proxies; examining the
outcomes of longitudinal goals-of-care discussions
Dyad-targeted palliative care interventions
Interventions to increase workforce diversity; interventions tailored to different cultures and
languages and rural populations

Definition of abbreviation: ACP = advanced care planning.

complex interventions such as ACP and
symptom management (264). Therefore,
multiple outcomes (e.g., patient- and familycentered measures) and implementation
outcomes like adoption and sustainability
and the use of newer study designs such as
MOST (multiphase optimization strategy)
(265) are needed to examine which speciﬁc
component(s) of the intervention are
effective, including measuring speciﬁc
impacts proximal to the intervention and
potential harms (20). Research is needed to
identify when to initiate palliative care to
achieve maximal beneﬁt for patients and
families for speciﬁc chronic respiratory
illnesses (e.g., COPD) (48). Effective
telehealth-based palliative care delivery
models that include sustainable payment
models (266) are critical to reaching patients
living in rural and/or underserved
communities.
Developing and testing primary
palliative care training interventions that are
practical, scalable, and embedded within
existing clinical settings is an additional
priority. The critical shortage of palliative
care specialists (267) necessitates
pulmonary–critical care clinician
competency in fundamental palliative care
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skills. More work is also needed to develop
models with integrated or comanagement of
primary and secondary palliative care in
ways that are acceptable, sensible, and
efﬁcient (268). Application of novel
methodologies and study designs are needed
to improve the quality of palliative care
evidence in pulmonary and critical care
medicine. Examples include quasiexperimental/natural experiments, adaptive
designs, hybrid and pragmatic trials, and
mixed methods research. Pulmonary
palliative care interventions that have been
conducted in ICU settings can guide this
work; however, further research is urgently
needed for seriously ill patients and their
caregivers managed in pulmonary outpatient
clinics. Lastly, it is critical to include people
of color, non-English speakers, and members
of rural communities in future studies to
ensure a better understanding of their unique
palliative care needs (269). Expanding
funding for the cultural and linguistic
adaptation of effective palliative care
interventions to diverse populations offers a
high-value opportunity to broaden the reach
of palliative care.
The “culture problem” of integrating
palliative care into pulmonary and critical

care medicine is a challenge that is
not unique to the ﬁeld. Despite
recommendations from professional
societies to offer palliative care to patients
with advanced cancer, the adoption of
palliative care is variable depending on the
service and setting (22, 270). Therefore,
trials are needed to test the effectiveness of
efﬁcacious interventions with primary aims
focusing on the outcomes of
implementation science, such as clinician
adoption of the intervention and
sustainability in different practice settings.
A clearer framework could help the ﬁeld
guide and successfully implement palliative
care while enhancing its
scalability. Palliative care interventions in
the ICU and pulmonary outpatient settings
appear promising, but more research is
needed to understand the full range of
patient, family, and healthcare system
impacts (271).
Technological advancements, including
the leveraging of electronic health record
systems for useful clinical tasks and the use of
methods such as artiﬁcial intelligence and
machine learning, are likely to accelerate the
conduct of future clinical research. Examples
include patient identiﬁcation for study
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criteria and outcomes collection. Technology
in the form of telehealth can be used to
support clinician education, patient selfmanagement, and improved care delivery
and disparities. A number of self-directed
mobile app-based interventions targeting
psychological distress and physical
symptoms are also available (272–274).
Lastly, researchers from around the globe can
meet and collaborate without traveling by
using available technology to access data and
conduct collaborative research to accelerate
innovation.
Other important research priorities
include characterizing the impact of
clinicians engaging in early and regular
GOC discussions on “in-the-moment
decision-making” and goal concordant
care (191, 275). The palliative care ﬁeld is
making progress in developing measures of
goal concordance (276) and applying them
in research studies. Approaches toward
managing common symptoms in
respiratory illnesses, such as acute
breathlessness, cough, and fatigue, require
further investigation to improve the
efﬁcacy of patient and caregiver self-care
management as well as their QOL. For
example, the effectiveness of speciﬁc opioid
formulations and routes as well as target

illnesses has not been established.
Furthermore, the effects in daily life of
supplemental oxygen in patients without
hypoxemia and the use of heliox on
dyspnea and functional ability are
unknown (277). In addition, studies on the
effects of nonpharmacological approaches
to symptom management, such as graded
exercise therapy for fatigue, are important
next steps to tailor care. Lastly, caregiver
research is a priority as the demand for
informal caregiver involvement in patient
care increases while the caregiver
population ages. Developing and evaluating
dyad-targeted palliative care interventions
for patients and caregivers living with
serious respiratory illnesses is important as
they may improve QOL, and this research
can inform state and federal policy
initiatives on caregiver support.
In summary, to comprehensively
address the research priorities identiﬁed
by the members of this committee
(Table 9), it is imperative to engage a
broad group of partners that includes
patients, families, caregivers,
policymakers, and funders
(e.g., National Institutes of Health,
Patient-Centered Outcomes Research
Institute, and foundations) to help

prioritize topics and ensure adequate
funding (264, 265).

Conclusions
Patients with serious respiratory illness and
their caregivers suffer from
signiﬁcant physical, emotional, spiritual, and
ﬁnancial burdens and are in need of early
palliative care to help guide treatment
planning. Ideally, primary palliative care
should be initiated by pulmonary–critical
care clinicians early in the care continuum
seamlessly alongside disease-directed
treatments. Secondary palliative care has an
important complementary role in supporting
primary palliative care by providing
interprofessional expertise as needed. Given
the robust evidence-based support for
palliative care in improving QOL among
patients with serious illness, the provision of
this care is a fundamental right for any
patient and/or caregiver who may beneﬁt.
This multisociety policy statement presents
essential palliative care recommendations,
values, and guiding principles among
patients with serious respiratory illness and is
designed to provide guidance for clinicians
and to inform policy initiatives. 䊏
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